Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cellectis S.A. - American Depositary Shares
(NQ:
CLLS
)
3.190
+0.060 (+1.92%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
80,630
Open
3.170
Bid (Size)
2.790 (1,300)
Ask (Size)
3.410 (1,600)
Prev. Close
3.130
Today's Range
3.160 - 3.300
52wk Range
1.100 - 5.480
Shares Outstanding
45,484,310
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cellectis Reports Third Quarter 2025 Financial Results and Provides Business Update
November 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Earnings Scheduled For November 7, 2025
November 07, 2025
Via
Benzinga
Performance
YTD
+76.2%
+76.2%
1 Month
-23.5%
-23.5%
3 Month
+20.4%
+20.4%
6 Month
+111.3%
+111.3%
1 Year
+80.2%
+80.2%
More News
Read More
Cellectis Earnings Preview
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 4, 2025
August 04, 2025
Via
Benzinga
Cellectis to Present a Development Update for eti-cel at ASH 2025
November 03, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Report Third Quarter Financial Results on November 7, 2025
October 31, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
October 20, 2025
Via
Benzinga
Cellectis’ R&D Day Highlights Lasme-cel’s Potential to Address Significant Unmet Need for Patients with r/r B-ALL
October 16, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Thursday's session: gap up and gap down stocks
October 16, 2025
Via
Chartmill
Enerpac Tool Group Posts Upbeat Results, Joins Praxis Precision Medicines, J B Hunt, Salesforce And Other Big Stocks Moving Higher On Thursday
October 16, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Keep You Up At Night This Month
October 16, 2025
Via
Benzinga
Stay updated with the stocks that are on the move in today's pre-market session.
October 16, 2025
Via
Chartmill
Cellectis Hosts R&D Day Today Showcasing Pipeline Progress and Long-Term Value Drivers
October 16, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
October 07, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
September 29, 2025
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 29, 2025
Via
Benzinga
Inventiva, MoonLake Immunotherapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 29, 2025
Via
Benzinga
Topics
Stocks
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
September 29, 2025
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 19, 2025
Via
Benzinga
Top 5 Biotech Stocks With Strong Momentum
August 28, 2025
Via
Benzinga
Cellectis Reports Second Quarter 2025 Financial Results & Business Updates
August 04, 2025
From
Cellectis Inc.
Via
GlobeNewswire
Why Celestica Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
July 29, 2025
Via
Benzinga
Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025
July 28, 2025
From
Cellectis Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
July 25, 2025
Via
Benzinga
What's going on in today's session
July 25, 2025
Via
Chartmill
Frequently Asked Questions
Is Cellectis S.A. - American Depositary Shares publicly traded?
Yes, Cellectis S.A. - American Depositary Shares is publicly traded.
What exchange does Cellectis S.A. - American Depositary Shares trade on?
Cellectis S.A. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Cellectis S.A. - American Depositary Shares?
The ticker symbol for Cellectis S.A. - American Depositary Shares is CLLS on the Nasdaq Stock Market
What is the current price of Cellectis S.A. - American Depositary Shares?
The current price of Cellectis S.A. - American Depositary Shares is 3.190
When was Cellectis S.A. - American Depositary Shares last traded?
The last trade of Cellectis S.A. - American Depositary Shares was at 11/07/25 04:00 PM ET
What is the market capitalization of Cellectis S.A. - American Depositary Shares?
The market capitalization of Cellectis S.A. - American Depositary Shares is 145.09M
How many shares of Cellectis S.A. - American Depositary Shares are outstanding?
Cellectis S.A. - American Depositary Shares has 145M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today